The Betapharm Acquisition: DRL`s Inorganic Growth Strategy in Europe (French)
Details
Case Code:
OFBSTR249
Case Length:
19
Period:
Pub Date:
Teaching Note:
YES
Price (Rs):
500
Organization:
Dr. Reddy’s Laboratories Ltd.
Industry:
Pharmaceuticals & Biotech
Country:
Germany; India
Themes:
M&A,Operations Strategy, Market Entry
Abstract
Learning Objectives
The case is structured to achieve the following Learning Objectives:
Keywords
betapharm Arzneimittel GmbH, Dr. Reddy's Laboratories Ltd., Mergers and Acquisitions, Strategic Management, German Pharmaceutical Generic Market, Value Creation, Drug Discovery and Development, Low-Cost Manufacturing Outsourcing, Corporate Social Responsibility, Ranbaxy Laboratories Limited, Political and Regulatory Environment, Economic Optimisation of Pharmaceutical Care Act, International Market Expansion, Globalization, Post-merger Integration Plan